| NCT Number | NCT05977400 |
| Lead Sponsor | Sharp HealthCare
Collaborators: University of Pittsburgh, Morgan Stanley Children's Hospital, University of Louisville, Sharp Mary Birch Hospital for Women & Newborns, Children's Hospital of Philadelphia, Jefferson Medical College of Thomas Jefferson University, University of South Florida, Westchester Medical Center, Yale University, The University of Texas Health Science Center at San Antonio, Penn State University, State University of New York - Downstate Medical Center, Mount Sinai Hospital, Canada |
| Conditions | Premature Birth, Antibiotics, Neurodevelopment |
| Enrollment | 802 participants |
| Start Date | 2024-04 |
| Primary Completion | 2029-03 (estimated) |
| Study Completion | 2029-03 (estimated) |
| Updated on ClinicalTrials.gov | 2023-08-04 |